Company intelligence / Profile preview

Luyin Investment Group

Yantai, Shandong, Chinaluyin.cn ↗

Ownership: Private
Development stage: Other

Overview

Luyin Investment Group is a diversified holding and investment company with significant activities in powder metallurgy materials and salt chemicals. Through its subsidiaries—such as Wuhu Luye Pharmaceutical Co., Ltd., Shandong Bioanty Biological Technology Co., Ltd., and others—it is active in biotech drug R&D, traditional Chinese medicine production/sales, animal health products, ginseng industry development, and more. Its biopharma-related entities are engaged in innovative drug discovery/development across multiple modalities including biologics and antibodies.

Modalities: Biologic drugsAntibody therapiesTraditional Chinese Medicine
Industry: Biotech

Beyond the preview

Go deeper on Luyin Investment Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Luyin Investment Group.

Explore the full profile